Oxygen-induced seizures and inhibition of human glutamate decarboxylase and porcine cysteine sulfinic acid decarboxylase by oxygen and nitric oxide

J Biomed Sci. 2001 Jul-Aug;8(4):359-64. doi: 10.1007/BF02258378.

Abstract

The recombinant forms of the two human isozymes of glutamate decarboxylase, GAD65 and GAD67, are potently and reversibly inhibited by molecular oxygen (Ki = 0.46 and 0.29 mM, respectively). Inhibition of the vesicle-associated glutamate decarboxylase (GAD65) by molecular oxygen is likely to result in incomplete filling of synaptic vesicles with gamma-aminobutyric acid (GABA) and may be a contributing factor in the genesis of oxygen-induced seizures. Under anaerobic conditions, nitric oxide inhibits both GAD65 and GAD67 with comparable potency to molecular oxygen (Ki = 0.5 mM). Two forms of porcine cysteine sulfinic acid decarboxylase (CSADI and CSADII) are also sensitive to inhibition by molecular oxygen (Ki = 0.30 and 0.22 mM, respectively) and nitric oxide (Ki = 0.3 and 0.2 mM, respectively). Similar inhibition of glutamate decarboxylase and cysteine sulfinic acid decarboxylase by two different radical-containing compounds (O2 and NO) is consistent with the notion that these reactions proceed via radical mechanisms.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Carboxy-Lyases / antagonists & inhibitors*
  • Glutamate Decarboxylase / antagonists & inhibitors*
  • Humans
  • Nitric Oxide / pharmacology*
  • Oxygen / adverse effects*
  • Oxygen / pharmacology
  • Recombinant Proteins / antagonists & inhibitors
  • Seizures / chemically induced*
  • Swine

Substances

  • Recombinant Proteins
  • Nitric Oxide
  • Carboxy-Lyases
  • Glutamate Decarboxylase
  • sulfoalanine decarboxylase
  • Oxygen